Olumide Soroye
Verisk AnalyticsAbout Olumide Soroye
Olumide Soroye is an independent director of Verisk and President & CEO of Intelligent Operating Solutions (IOS) at Fortive Corporation. He is 52, has served on Verisk’s board since 2022, and currently chairs the Finance and Investment Committee; he also serves on the Risk Committee and the Executive Committee . His background spans data-enabled workflow software leadership, CoreLogic transformation (2013–2021), QuinStreet technology leadership, and over a decade as a McKinsey partner advising growth, product, and sales strategy .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Fortive Corporation (Intelligent Operating Solutions) | President & CEO | Aug 2021–present | Oversees portfolio with strong growth, margins, and cash flow profile; software/data-enabled workflows |
| CoreLogic | Managing Director | Sept 2013–Aug 2021 | Led transformation to highly profitable growth via data-driven digital workflow innovation and strategic acquisitions |
| QuinStreet | SVP of Technology | Not disclosed | Technology leadership (prior to CoreLogic) |
| McKinsey & Company | Partner | >10 years | Focused on growth, product, and sales strategy across technology sector; advised >50 corporations |
External Roles
| Organization | Role | Public Company Directorships | Notes |
|---|---|---|---|
| Fortive Corporation (IOS) | President & CEO | None disclosed | External operating role contemporaneous with Verisk board service |
Board Governance
| Committee | Role | Meetings in 2024 | Independence Status |
|---|---|---|---|
| Finance & Investment | Chair | 4 | Board determined all members independent (Nasdaq rules) |
| Risk | Member | 4 | Board determined all members independent (Nasdaq rules) |
| Executive | Member | 0 (did not meet in 2024) | Independent Board Chair + Chairs of other committees compose membership |
| Board attendance | — | Board met 4 times in 2024; all directors ≥75% attendance | Board independence: 10 of 11 independent directors including Soroye |
- The Finance & Investment Committee advises on capital structure, capital market transactions, financing, strategic investments, acquisitions, divestitures, and oversight of investment policies and advisors .
- The Risk Committee oversees enterprise risk management and strategic/operational risks including cyber, technology, information security, privacy, and regulatory compliance (coordinated with Audit) .
Fixed Compensation
| Component | Structure | 2024 Amount (Soroye) |
|---|---|---|
| Annual cash retainer | $105,000 for non-employee directors | $97,581 (may elect form/deferral; amounts can vary) |
| Committee chair fee | $15,000 for chairs other than Audit and TMC (Audit/TMC chairs $20,000) | Included in fees earned |
| Independent Chair premium | $150,000 (not applicable to Soroye) | N/A |
| Total cash + equity (2024) | Retainer + equity grant | $330,000 total ($97,581 cash; $232,419 stock) |
Director compensation program terms:
- Retainer election options: cash, deferred cash, common stock, deferred common stock, or combination; cash paid quarterly in arrears; any issued common stock vests immediately; deferred amounts payable/issuable upon separation from the board .
- Director compensation limit: total cash plus grant-date fair value of equity ≤$750,000/year under 2021 Equity Incentive Plan .
Performance Compensation
| Equity Component | Value/Type | Vesting/Settlement | Notes |
|---|---|---|---|
| Annual equity award (2024) | $210,000 value | Director elects DSUs (vest/settle at separation) or RSUs (vest at next annual meeting or 1-year anniversary) | Time-based; no performance metrics for director awards |
| Option awards | Eliminated for directors as of May 2023 | — | Legacy options remain outstanding for some directors |
| Soroye outstanding awards (12/31/2024) | 3,103 stock awards | Outstanding stock awards count disclosed | Aggregate outstanding awards across award types |
| Soroye outstanding options (12/31/2024) | 738 options | Legacy grants only | Reflects elimination of new director option grants |
Other Directorships & Interlocks
| Relationship | Details | Governance relevance |
|---|---|---|
| CoreLogic linkage | Soroye previously CoreLogic managing director (2013–2021); Wendy Lane previously served on CoreLogic’s board | Historical network tie; not a related-party transaction disclosure |
Expertise & Qualifications
- Expertise in innovation, data, and technology; developed market-leading software and data-enabled workflow solutions .
- Track record accelerating growth and profitability across verticals; experience in corporate development and strategic acquisitions .
Equity Ownership
| Measure | Value | Detail |
|---|---|---|
| Beneficial ownership (Feb 21, 2025) | 4,688 shares | Less than 1% of class (140,276,165 shares outstanding) |
| Components of beneficial ownership | 738 options exercisable within 60 days; 847 RSUs that vest at next annual meeting or 1-year anniversary; 591 deferred stock units | Footnote breakdown for Soroye |
| Director ownership guideline | 6× annual base retainer ($105k × 6) | Soroye currently holds stock value exceeding guideline |
| Hedging/pledging | Prohibited for non-employee directors | Company policy bans pledging, hedging, shorting, options/futures trading, margin accounts |
Governance Assessment
- Board effectiveness: Soroye chairs Finance & Investment during an active capital allocation/M&A oversight period; deep operating/software and data expertise complements Verisk’s data analytics focus .
- Independence and attendance: Board-designated independent; served on Executive and Risk committees; directors met ≥75% attendance and attended 2024 annual meeting .
- Alignment: Majority of 2024 compensation delivered in equity (time-based RSUs/DSUs); strong director ownership guidelines (6× retainer) with Soroye in compliance; anti-hedging/pledging enhances alignment .
- RED FLAGS: None disclosed in proxy regarding hedging/pledging, option repricing for directors (program eliminated options in 2023), or attendance shortfalls; no related-party transactions for Soroye disclosed in reviewed sections .